Guidant Cautions Doctors on Defibrillators
From the Associated Press
Guidant Corp., which is being acquired for $27 billion by Boston Scientific Corp., cautioned doctors to check the voltage on certain implantable defibrillators after the company received reports of defective devices.
The Indianapolis medical device maker issued the warning for its Contak Renewal 3 RF and Contak Renewal 4 RF models of defibrillators, which shock the heart back to a normal rhythm.
